| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |